Cargando…
Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis
The treatment of pediatric myocarditis is controversial, and the benefits of intravenous immunoglobulin (IVIG) are inconclusive due to limited data. We searched studies from PubMed, MEDLINE, Embase, and Cochrane Library databases since establishment until October 1st, 2018. Thirteen studies met the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639391/ https://www.ncbi.nlm.nih.gov/pubmed/31320679 http://dx.doi.org/10.1038/s41598-019-46888-0 |
_version_ | 1783436457358131200 |
---|---|
author | Yen, Chun-Yu Hung, Miao-Chiu Wong, Ying-Chi Chang, Chia-Yuan Lai, Chou-Cheng Wu, Keh-Gong |
author_facet | Yen, Chun-Yu Hung, Miao-Chiu Wong, Ying-Chi Chang, Chia-Yuan Lai, Chou-Cheng Wu, Keh-Gong |
author_sort | Yen, Chun-Yu |
collection | PubMed |
description | The treatment of pediatric myocarditis is controversial, and the benefits of intravenous immunoglobulin (IVIG) are inconclusive due to limited data. We searched studies from PubMed, MEDLINE, Embase, and Cochrane Library databases since establishment until October 1st, 2018. Thirteen studies met the inclusion criteria. We included a total of 812 patients with IVIG treatment and 592 patients without IVIG treatment. The meta-analysis showed that the survival rate in the IVIG group was higher than that in the non-IVIG group (odds ratio = 2.133, 95% confidence interval (CI): 1.32–3.43, p = 0.002). There was moderate statistical heterogeneity among the included studies (I(2) = 35%, p = 0.102). However, after adjustment using Duval and Tweedie’s trim and fill method, the point estimate of the overall effect size was 1.40 (95% CI 0.83, 2.35), which became insignificant. Moreover, the meta-regression revealed that age (coefficient = −0.191, 95% CI (−0.398, 0.015), p = 0.069) and gender (coefficient = 0.347, 95% CI (−7.586, 8.279), p = 0.93) were not significantly related to the survival rate. This meta-analysis showed that IVIG treatment was not associated with better survival. The use of IVIG therapy in acute myocarditis in children cannot be routinely recommended based on current evidence. Further prospective and randomized controlled studies are needed to elucidate the effects of IVIG treatment. |
format | Online Article Text |
id | pubmed-6639391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-66393912019-07-25 Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis Yen, Chun-Yu Hung, Miao-Chiu Wong, Ying-Chi Chang, Chia-Yuan Lai, Chou-Cheng Wu, Keh-Gong Sci Rep Article The treatment of pediatric myocarditis is controversial, and the benefits of intravenous immunoglobulin (IVIG) are inconclusive due to limited data. We searched studies from PubMed, MEDLINE, Embase, and Cochrane Library databases since establishment until October 1st, 2018. Thirteen studies met the inclusion criteria. We included a total of 812 patients with IVIG treatment and 592 patients without IVIG treatment. The meta-analysis showed that the survival rate in the IVIG group was higher than that in the non-IVIG group (odds ratio = 2.133, 95% confidence interval (CI): 1.32–3.43, p = 0.002). There was moderate statistical heterogeneity among the included studies (I(2) = 35%, p = 0.102). However, after adjustment using Duval and Tweedie’s trim and fill method, the point estimate of the overall effect size was 1.40 (95% CI 0.83, 2.35), which became insignificant. Moreover, the meta-regression revealed that age (coefficient = −0.191, 95% CI (−0.398, 0.015), p = 0.069) and gender (coefficient = 0.347, 95% CI (−7.586, 8.279), p = 0.93) were not significantly related to the survival rate. This meta-analysis showed that IVIG treatment was not associated with better survival. The use of IVIG therapy in acute myocarditis in children cannot be routinely recommended based on current evidence. Further prospective and randomized controlled studies are needed to elucidate the effects of IVIG treatment. Nature Publishing Group UK 2019-07-18 /pmc/articles/PMC6639391/ /pubmed/31320679 http://dx.doi.org/10.1038/s41598-019-46888-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Yen, Chun-Yu Hung, Miao-Chiu Wong, Ying-Chi Chang, Chia-Yuan Lai, Chou-Cheng Wu, Keh-Gong Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis |
title | Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis |
title_full | Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis |
title_fullStr | Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis |
title_full_unstemmed | Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis |
title_short | Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis |
title_sort | role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: a systematic review and meta-analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639391/ https://www.ncbi.nlm.nih.gov/pubmed/31320679 http://dx.doi.org/10.1038/s41598-019-46888-0 |
work_keys_str_mv | AT yenchunyu roleofintravenousimmunoglobulintherapyinthesurvivalrateofpediatricpatientswithacutemyocarditisasystematicreviewandmetaanalysis AT hungmiaochiu roleofintravenousimmunoglobulintherapyinthesurvivalrateofpediatricpatientswithacutemyocarditisasystematicreviewandmetaanalysis AT wongyingchi roleofintravenousimmunoglobulintherapyinthesurvivalrateofpediatricpatientswithacutemyocarditisasystematicreviewandmetaanalysis AT changchiayuan roleofintravenousimmunoglobulintherapyinthesurvivalrateofpediatricpatientswithacutemyocarditisasystematicreviewandmetaanalysis AT laichoucheng roleofintravenousimmunoglobulintherapyinthesurvivalrateofpediatricpatientswithacutemyocarditisasystematicreviewandmetaanalysis AT wukehgong roleofintravenousimmunoglobulintherapyinthesurvivalrateofpediatricpatientswithacutemyocarditisasystematicreviewandmetaanalysis |